View in EDS

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Saved in:
Bibliographic Details
Title: Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
Authors: Tatovic D; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., McAteer MA; Midatech Pharma PLC, Cardiff, UK., Barry J; Midatech Pharma PLC, Cardiff, UK., Barrientos A; Midatech Pharma PLC, Cardiff, UK., Rodríguez Terradillos K; Midatech Pharma PLC, Cardiff, UK., Perera I; Midatech Pharma PLC, Cardiff, UK., Kochba E; NanoPass Technologies Ltd., Nes Ziona, Israel., Levin Y; NanoPass Technologies Ltd., Nes Ziona, Israel., Dul M; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Coulman SA; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Birchall JC; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., von Ruhland C; Central Biotechnology Services, Cardiff University, Cardiff, UK., Howell A; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Stenson R; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Alhadj Ali M; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Luzio SD; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Dunseath G; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Cheung WY; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Holland G; Swansea Trials Unit, Swansea University Medical School, Swansea, UK., May K; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK., Ingram JR; Division of Infection & Immunity, Cardiff University School of Medicine, Cardiff, UK., Chowdhury MMU; Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK., Wong FS; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Casas R; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden., Dayan C; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children´s Hospital, Linköping University, Linköping, Sweden.
Source: Immunotherapy advances [Immunother Adv] 2022 Jan 27; Vol. 2 (1), pp. ltac002. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101776979 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-4303 (Electronic) Linking ISSN: 27324303 NLM ISO Abbreviation: Immunother Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-4303
DOI:10.1093/immadv/ltac002